Clinical Trials Logo

Striae Distensae clinical trials

View clinical trials related to Striae Distensae.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06000839 Completed - Oxidative Stress Clinical Trials

A Safety and Effectiveness Study of CELLBOOSTER® Lift (Stabilized Booster Complex Using CHAC Technology)

Start date: October 7, 2022
Phase: N/A
Study type: Interventional

The current post-market clinical investigation has been designed to evaluate the efficacy and safety of CELLBOOSTER® Lift, a HA-based product marketed by SUISSELLE SA. For this purpose, healthy subjects with signs of skin aging with mild to moderate wrinkles, skin laxity, dry and dull skin on the face, received a 3-session treatment and were followed-up over a 4-month period after the initial injection. Several objective measurements of skin quality were performed with different parameters: skin elasticity, density, dryness, microcirculation, wrinkles, color/homogeneity. Clinical improvement was also evaluated, as well as subject and investigator satisfactions. The safety of the injections was also followed with injection site reactions and adverse events collection.

NCT ID: NCT05461755 Completed - Striae Distensae Clinical Trials

Treatment of Striae Distensae With Fractional Radiofrequency and Topical Tretinoin

Start date: November 22, 2022
Phase: Phase 2
Study type: Interventional

The study aims to explore the potential of combination therapy with fractional radiofrequency and topical tretinoin for treatment and overall improvement of striae albae. We also aim to assess subject satisfaction, local skin responses and adverse effects/reactions in relation to the treatments, alone and in combination.

NCT ID: NCT05097573 Completed - Stretch Mark Clinical Trials

Clinical Evaluation of the Efficacy of Fractional Radiofrequency for the Treatment and Reduction of Stretch Marks

Start date: May 9, 2019
Phase: N/A
Study type: Interventional

This is a prospective, single centre, evaluator-blind study of the performance of fractional radiofrequency (RF) for the treatment and revision of stretch marks. The study will evaluate the progress of 15 subjects requesting treatment of stretch marks. The study will involve four treatments on both sides of the face with 4 week intervals between each treatment. Subjects will be followed at 12 and 16 weeks after their last treatment. Analysis will be performed on all subjects who receive at least one treatment.

NCT ID: NCT05097157 Completed - Acne Clinical Trials

Study To Assess A Radiofrequency Microneedling Device For Dermatologic Conditions

Start date: September 3, 2019
Phase: N/A
Study type: Interventional

Subjects are to be enrolled in this clinical study if they are 18 - 55 years old. Up to 120 subjects will be enrolled at multiple study centers. Subjects may receive up to 5 treatments for a wide array of dermatologic conditions in which electrocoagulation and hemostasis is a viable mechanism for means of improvement.

NCT ID: NCT04956367 Completed - Striae Gravidarum Clinical Trials

Efficacy of Fractional Carbon Dioxide Laser Combined With Platelet-rich Plasma

Start date: July 1, 2019
Phase: Phase 3
Study type: Interventional

This study determined the efficacy of ablative fractional carbon dioxide laser combined with autologous platelet-rich plasma versus ablative fractional carbon dioxide laser with placebo in the treatment of striae gravidarum of postpartum Filipino women.

NCT ID: NCT04489901 Completed - Pregnancy Related Clinical Trials

Stria Gravidarum and Olive Oil for Pregnancy Women

Start date: February 15, 2019
Phase: N/A
Study type: Interventional

The aim of this study was to investigate the clinical efficacy of olive oil on the severity and progression of striae gravidarum. This randomized controlled clinical trial included 156 primipara women who were early third trimester. They were randomly allocated into two groups: an experimental group and a control group. Women in the experimental group applied olive oil to their abdomen twice a day in the morning and evening. The control group had no intervention.

NCT ID: NCT04165226 Completed - Striae; Albicantes Clinical Trials

LLLT and Fractional CO2 Laser in the Treatment of Stria Alba

Start date: November 24, 2018
Phase: N/A
Study type: Interventional

Stria alba (aka white or atrophic stretch marks) is a very common dermatologic condition that causes major psychological distress to those afflicted. We study the effect of low level light therapy using infra red diode 808/915 nm laser in comparison to fractional CO2 alone and combined both therapies.

NCT ID: NCT03858543 Completed - Striae Distensae Clinical Trials

Fractional Laser Assisted Delivery of Sculptra® for the Treatment of Striae

FADeS
Start date: July 15, 2019
Phase: Early Phase 1
Study type: Interventional

This study evaluates the efficacy of treatment of striae distensae using the combined modality of fractional laser and poly-L lactic acid (Sculptra).

NCT ID: NCT03390439 Completed - Striae Distensae Clinical Trials

Treatment of Atrofic Striae With Percutaneous Collagen Induction Therapy Versus Fractional Nonablative Laser

Start date: July 1, 2017
Phase: N/A
Study type: Interventional

As atrophic striae are common dermatological conditions. Various therapeutic modalities have been employed in the treatment of striae distensae, mainly in striae rubra. There are few studies that include the treatment of striae alba. The non-ablative fractionated laser and, more recently, microneedling are two distinct treatments, but they are widely used in dermatologist practice. The present randomized clinical trial is aimed at evaluating and evaluating the response of microneedle and fractional non-ablative laser Nd-yap 1340 in the treatment of abdominal striae alba.

NCT ID: NCT03377231 Completed - Stretch Mark Clinical Trials

Prevention and Treatment of Stretch Marks With Stratamark™

Start date: July 11, 2013
Phase: Phase 4
Study type: Interventional

Stretch marks (striae distensae) are a form of scarring that is a natural result of pregnancy, obesity and in some instances occur due to puberty or steroid use. For some people, the stretch marks do not cause a problem, but in many circumstances they can cause physical symptoms such as itchiness, tenderness and pain. For many people stretch marks are also embarrassing and can have detrimental effects on a patient's mood and self-esteem. Stretch marks that result from pregnancy most commonly occur on the abdomen, breasts and thighs. Topical silicone gel was developed nearly thirty years ago to be used in the treatment of widespread hypertrophic scars (abnormal scars, which may be red or raised/depressed itchy or painful). Since this time it has been used successfully on most scar types. . Since stretch marks are a form of scarring it is thought that topical silicone gel may be helpful for this scar type also. Stratamark™ has been developed using different forms of silicone polymers, in a gel format, that dries to form a very thin and flexible silicone gel sheet making it a convenient therapy for the treatment and prevention of stretch marks. The aim of this clinical research study is to prove or disprove the efficacy, safety and tolerability of Stratamark™ in the prevention and treatment of stretch marks. In addition, the knowledge gained from this study may be of benefit to many future patients